— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
10-fold rise in obesity surgery in England since 2000
The use of bariatric or weight loss surgery has increased ten-fold in NHS hospitals in England since 2000, finds a study published on bmj.com today.
One reason for this rapid rise is increased demand from obese patients as they become more aware of surgery as a viable treatment option, suggest the researchers.
Bariatric surgery is performed on people who are dangerously obese, for the purpose of losing weight. This is usually achieved by reducing the size of the stomach with a surgical band (gastric banding), by re-routing the small intestines to a small stomach pouch (gastric bypass), or by removing a portion of the stomach (sleeve gastrectomy).
Bariatric surgery has been shown to reduce the risk of death, hospital admission, and long term cost to the health service. It is recommended by the National Institute for Health and Clinical Excellence (NICE) for people with 'morbid obesity' (body mass index of at least 40 or of at least 35 if accompanied by coexisting disease that could be improved by weight loss) for whom all non-surgical treatments for weight loss have failed. But little is known about who is actually having bariatric surgery in England.
So a team of researchers based at Imperial College London set out to analyse national outcomes after surgery for obesity in the NHS in England.
Using the Hospital Episode Statistics database, they identified all adult patients who had a first elective bariatric procedure (gastric bypass, gastric banding or sleeve gastrectomy) between April 2000 and March 2008.
Mortality rates 30 days and one year after surgery were recorded, as well as duration of hospital stay and unplanned readmission rates.
A total of 6,953 bariatric procedures were carried out during the study period. The number of procedures rose more than ten-fold from 238 in 2000 to 2,543 in 2007.
Patients selected for gastric banding had lower post-surgery mortality and readmission rates and a shorter length of stay than those selected for gastric bypass.
Patients with comorbidities showed poorer post-surgery outcomes than did other patients.
The percentage of laparoscopic (keyhole) procedures also increased during this time, from 28% in 2000 to 75% in 2007. However, no significant increase in mortality or unplanned readmission was seen over the study period, suggesting that laparoscopy has been introduced in a safe manner into the NHS, say the authors.
They suggest: 'In conjunction with the growing level of obesity, as patients become more aware of surgery as a viable treatment option, demand for surgery among morbidly obese patients increases.'
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Breakthrough makes lab-produced stem cells safer for humans
Magnetic device studied as treatment for heartburn and acid reflux
Injections of licorice ingredient show promise as treatment for cocaine addiction
Sequences capture the code of the common cold